Table 2. Effects of antioxidants on the inhibitory effects of DZ and DZO on neurite outgrowth.
Treatment | Longest neurite length (μm) |
Minor neurite length (μm) |
No. neurites/cell |
---|---|---|---|
Control | 140.3 ± 6.8 | 22.0 ± 0.7 | 4.7 ± 0.1 |
PBN | 172.4 ± 15.4 | 13.5 ± 0.7# | 5.0 ± 0.2 |
Mel | 149.7 ± 15.5 | 21.0 ± 1.4 | 4.1 ± 0.2 |
DZ | 64.8 ± 3.0# | 15.5 ± 0.4# | 4.6 ± 0.1 |
DZ + PBN | 210.5 ± 20.4# | 15.7 ± 0.9# | 5.5 ± 0.4 |
DZ + Mel | 175.3 ± 15.6 | 16.2 ± 0.8# | 4.6 ± 0.2 |
DZO | 51.8 ± 2.3# | 15.6 ± 0.5# | 4.6 ± 0.2 |
DZO + PBN | 188.1 ± 21.8* | 20.3 ± 1.1* | 5.4 ± 0.3 |
DZO + Mel | 138.2 ± 12.2 | 16.8 ± 1.2# | 4.7 ± 0.2 |
Astrocytes were pre-treated with 200 μM melatonin (Mel) or 100 μM PBN for 3 h prior to washout and treatment with 10 μM DZ or DZO for 24 h. After further wash-out, astrocytes were co-cultured with hippocampal neurons for 48 h, as described in Methods. Results represent the mean (± SEM) of at least 60 cells per treatment group. Significantly different from untreated control,
, p<0.05;
, p<0.001.